—

Omega Fund Management, LLC

Q4 2025 13F Holdings

  • Location
    boston, MA
  • Num holdings

    11

  • Value ($000)

    $286,520

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001637359
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
N
NUVB

Nuvation Bio

COMMON STOCK CLASS A
67080N101
$72.41M
25 %

8,081,089

---

BridgeBio Oncology Therapeutics Inc.

COMMON STOCK
107924102
$41.19M
14 %

3,289,661

---

Beta Bionics Inc.

COMMON STOCK
08659B102
$40.1M
14 %

1,316,183

---

Bicara Therapeutics Inc.

COMMON STOCK
055477103
$37.1M
13 %

2,204,650

---

Kestra Med Technologies Ltd

COMMON STOCK
G52441105
$36.43M
13 %

1,373,591

---

Upstream Bio Inc.

COMMON STOCK
91678A107
$36.01M
13 %

1,326,293

E
ENGN

enGene Holdings Inc.

COMMON STOCK
29286M105
$7.91M
3 %

876,357

A
ALMS

Alumis Inc.

COMMON STOCK
022307102
$6.38M
2 %

653,223

S
SANA

Sana Biotechnology, Inc.

COMMON STOCK
799566104
$3.43M
1 %

843,750

---

ImageneBio, Inc.

COMMON STOCK
45175G207
$3.14M
1 %

455,361

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 11